The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
Despite recent developments in cancer diagnostics and treatment modalities, mortality rates maintain high in non-small cell lung cancer (NSCLC)[1]. One of the factors contributing to high mortality rates is progressive unintentional weight loss of body weight and muscle mass (i.e. cachexia [2].
Source: Lung Cancer - Category: Cancer & Oncology Authors: J.H.R.J. Degens, K.J.C. Sanders, E.E.C. de Jong, H.J.M. Groen, E.F. Smit, J.G. Aerts, A.M.W.J. Schols, A-M.C. Dingemans Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Weight Loss